EAN News

Abstract submission and registration are NOW OPEN for the 11th Congress of the European Academy of Neurology!

Interested in strengthening your advocacy skills to help raise the voice of brain health? Find out more about the EAN Advocacy Training programme, taking place March-June 2025.

Dr Giacomo Sferruzza, the new EAN Resident & Research Fellow Section (RRFS) Chair, gives an overview of the RRFS Office team, and their aims and priorities for the term ahead.

We are excited to announce the publication of our Sustainability Report 2024, which highlights the steps we have taken to integrate sustainable practices throughout our operations and supply chains.

Our paper of the month for November presents the findings from two large trials comparing the safety and efficacy of evobrutinib with teriflunomide in adults with a diagnosis of relapsing MS.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for November 2024.

The EAN is looking for a candidate who will provide support to the EAN Guideline Production Group and Guideline Taskforces as a Junior Methodologist. Application is open until 29 November.

Professor Stephan Zierz, an innovator in the field of neurology and neuromuscular medicine, sadly passed away on April 22 at the age of 69.

The EAN has published a new e-book, showcasing the aims and achievements of the Brain Health Mission, titled 'Brain Health Mission: The Story So Far'.

Prof. Didier Leys, current Editor-in-Chief of the European Journal of Neurology (since 2020) talks about his role in the journal's development, as part of our series celebrating its 30th anniversary.

Watch a full recording of this special event on ‘Prioritising Brain Health: A Global Imperative for Public Health’, held alongside the G7 Health Ministers Meeting on 8 October, in Ancona, Italy.

Prof. Kailash Bhatia, Professor of Clinical Neurology at the Department of Clinical and Movement Neuroscience of the Institute of Neurology, UCL, Queen Square, London, was voted in as President-Elect of the EAN at the EAN Congress 2024.

Our Paper of the Month for October is a phase 2, double-blind, randomised, placebo-controlled trial investigating the efficacy of a monoclonal antibody (Lu AG09222) that inhibits PACAP signalling.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for October 2024.

New members applying now will receive membership for the rest of 2024, plus 2025; existing members renewing in October will get a 5% discount; and associate members have a free month of access to congress content on demand!